Keith Lavan's most recent trade in Petros Pharmaceuticals Inc was a trade of 975 Common Stock, par value $0.0001 per share done . Disclosure was reported to the exchange on Dec. 1, 2020.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Petros Pharmaceuticals Inc | Keith Lavan | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Dec 2020 | 975 | 975 | - | - | Common Stock, par value $0.0001 per share |